The overall goal of this research program is to elucidate mechanisms of intracellular signalling by pp60V-src, with an emphasis on the interaction of pp60v-src with signalling pathways utilized during normal mitogenesis. For the first Specific Aim, we propose a molecular characterization of pp42, a protein whose tyrosine phosphorylation accompanies a wide variety of signalling events, including transformation by src, and mitogenic stimulation. The second and third Specific Aims propose feasibility studies for, respectively, the development of improved biochemical or genetic tools to identify and isolate additional signalling intermediates. 1. Purification and characterization of pp42. Protein tyrosyl phosphorylation is undoubtedly a key first step in the mechanism of action of pp60v-src and of the tyrosine kinase mitogen receptors. We have identified and are purifying a 42,000 Mr protein which is the best candidate so far identified for a signalling intermediary for pp60v-src and other tyrosine kinases. We propose to finish the purification of this protein, and to characterize it by obtaining amino acid sequence information, raising antisera against it and cloning and sequencing the gene. 2. Identification and isolation of pp60v-src substrates. We propose to use partially transforming src mutants which we have isolated, cloned and sequenced, to identify and purify additional cellular proteins which might interact with pp60v-src in functionally significant ways. We will analyze the biochemical basis for the substrate selectivity of these mutant src proteins, an over-express them with a Baculovirus vector to produce sufficient quantities of wild-type and mutant pp60v-src to use as affinity reagents for the isolation of cellular target proteins. 3. Cellular mutants refractory to oncogenesis by src. We wish to generate biological reagents which will allow us to study signal transduction pathways utilizing the same protocols which have been used successfully in identifying oncogenes (e.g. DNA transfection and molecular genetics). Thus, we propose to construct or identify cell lines refractory to transformation by src, and will use DNA transfection to search for genes which confer transformability on these cells. Such genes are candidate """"""""signal transduction"""""""" genes. We already have identified one such cell line, TNR9 cells, a 3T3 derivative isolated on the basis of its resistance to TPA-induced mitogenesis. We also describe protocols to isolate additional src refractory cell lines.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA039076-07
Application #
3482431
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1984-06-01
Project End
1994-05-31
Budget Start
1990-06-01
Budget End
1991-05-31
Support Year
7
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Kumar, N Vinay; Eblen, Scott T; Weber, Michael J (2004) Identifying specific kinase substrates through engineered kinases and ATP analogs. Methods 32:389-97
Eblen, Scott T; Slack-Davis, Jill K; Tarcsafalvi, Adel et al. (2004) Mitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesion. Mol Cell Biol 24:2308-17
Vomastek, Tomas; Schaeffer, Hans-Joerg; Tarcsafalvi, Adel et al. (2004) Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists. Proc Natl Acad Sci U S A 101:6981-6
Eblen, Scott T; Kumar, N Vinay; Shah, Kavita et al. (2003) Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs. J Biol Chem 278:14926-35
Bakin, Robert E; Gioeli, Daniel; Bissonette, Eric A et al. (2003) Attenuation of Ras signaling restores androgen sensitivity to hormone-refractory C4-2 prostate cancer cells. Cancer Res 63:1975-80
Carson, Jonathan P; Behnam, Marcelina; Sutton, Jennifer N et al. (2002) Smac is required for cytochrome c-induced apoptosis in prostate cancer LNCaP cells. Cancer Res 62:18-23
Gioeli, Daniel; Ficarro, Scott B; Kwiek, Jesse J et al. (2002) Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem 277:29304-14
Eblen, Scott T; Slack, Jill K; Weber, Michael J et al. (2002) Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes. Mol Cell Biol 22:6023-33
Kulik, G; Carson, J P; Vomastek, T et al. (2001) Tumor necrosis factor alpha induces BID cleavage and bypasses antiapoptotic signals in prostate cancer LNCaP cells. Cancer Res 61:2713-9
Gioeli, D; Zecevic, M; Weber, M J (2001) Immunostaining for activated extracellular signal-regulated kinases in cells and tissues. Methods Enzymol 332:343-53

Showing the most recent 10 out of 63 publications